These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15773201)

  • 1. [Osteoporosis].
    Uebelhart B; Rizzoli R
    Rev Med Suisse; 2005 Jan; 1(1):68-71. PubMed ID: 15773201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S; Vai S
    Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
    Dimai HP
    Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis treatment].
    Uebelhart B; Rizzoli R
    Rev Med Suisse; 2007 Jan; 3(94):150-3. PubMed ID: 17354541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.
    Inderjeeth CA; Foo AC; Lai MM; Glendenning P
    Bone; 2009 May; 44(5):744-51. PubMed ID: 19130909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new treatment for post-menopausal osteoporosis: strontium ranelate.
    Rizzoli R
    J Endocrinol Invest; 2005; 28(8 Suppl):50-7. PubMed ID: 16323829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
    Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteoporosis: whom, when and how to treat?].
    Stepán J
    Cas Lek Cesk; 2009; 148(1):25-33. PubMed ID: 19634279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S
    Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The teriparatide in the treatment of severe senile osteoporosis.
    Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():249-58. PubMed ID: 17317460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevention and treatment of osteoporosis: a review.
    Cosman F
    MedGenMed; 2005 May; 7(2):73. PubMed ID: 16369451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucocorticoids and osteoporosis].
    Zikán V
    Vnitr Lek; 2007; 53(7-8):831-40. PubMed ID: 17915428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
    Neuprez A; Hiligsmann M; Scholtissen S; Bruyere O; Reginster JY
    Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitamin K2 (menatetrenone) and bone quality].
    Iinuma N
    Clin Calcium; 2005 Jun; 15(6):1034-9. PubMed ID: 15930719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic agents for disorders of bone and calcium metabolism. Osteoporotic fracture prevention by strontium ranelate].
    Nakamura T
    Clin Calcium; 2007 Jan; 17(1):80-7. PubMed ID: 17211097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in the treatment of osteoporosis].
    Sugimoto T
    Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strontium as therapy for osteoporosis.
    Marie PJ
    Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.